As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Moderator(s)

Ted E. Feldman, MD

Director, Cardiac Catheterization Laboratory, Evanston Hospital, Evanston, Illinois

Disclosures

Disclosure: Ted E. Feldman, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbott Laboratories; Boston Scientific
Received grants for clinical research from: Abbott Laboratories; Boston Scientific

Dr. Feldman does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the US Food and Drug Administration (FDA) for use in the United States.

Dr. Feldman does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Presenter(s)

Westby G. Fisher, MD

Director, Cardiac Electrophysiology, NorthShore University HealthSystem, Evanston, Illinois; Clinical Associate Professor of Medicine, Pritzker School of Medicine, The University of Chicago, Chicago, Illinois

Disclosures

Disclosure: Westby G. Fisher, MD, has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Medtronic, Inc.; Boston Scientific

Dr. Fisher does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Fisher does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Rena L. Silver, APN, CNP

Nurse Practitioner, Cardiology, NorthShore University HealthSystem, Evanston Hospital, Evanston, Illinois

Disclosures

Disclosure: Rena L. Silver, APN, CNP, has disclosed no relevant financial relationships.

Ms. Silver does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Ms. Silver does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

Ronald K. Miller, PhD

Scientific Director, Medscape, LLC

Disclosures

Disclosure: Ronald K. Miller, PhD, has disclosed no relevant financial relationships.

CME Reviewer(s)

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Peer Reviewer

The Peer Reviewer has disclosed no financial relationships.

CME

A Case-Based Approach to Improve Strategies to Reduce Risk for SCA Post-PCI

Authors: Ted E. Feldman, MD; Westby G. Fisher, MD; Rena L. Silver, APN, CNP
CME Released: 9/20/2011; Reviewed and Renewed: 4/15/2014
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 4/15/2015, 11:59 PM EST

Start Activity

Target Audience and Goal Statement

This activity is intended for electrophysiologists, interventional cardiologists, clinical cardiologists, and other allied healthcare professionals

The goal of this activity is to enhance the ability to protect patients at high risk for sudden cardiac death immediately after percutaneous coronary intervention (PCI).

Upon completion of this activity, participants will be able to:

Discuss patient discharge strategies to reduce the risk for sudden cardiac arrest post-PCI, including optimizing medical therapy and the role of devices like the wearable defibrillator

Disclosures

Moderator(s)

Ted E. Feldman, MD

Director, Cardiac Catheterization Laboratory, Evanston Hospital, Evanston, Illinois

Disclosures

Disclosure: Ted E. Feldman, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbott Laboratories; Boston Scientific
Received grants for clinical research from: Abbott Laboratories; Boston Scientific

Dr. Feldman does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the US Food and Drug Administration (FDA) for use in the United States.

Dr. Feldman does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Presenter(s)

Westby G. Fisher, MD

Director, Cardiac Electrophysiology, NorthShore University HealthSystem, Evanston, Illinois; Clinical Associate Professor of Medicine, Pritzker School of Medicine, The University of Chicago, Chicago, Illinois

Disclosures

Disclosure: Westby G. Fisher, MD, has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Medtronic, Inc.; Boston Scientific

Dr. Fisher does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Fisher does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Rena L. Silver, APN, CNP

Nurse Practitioner, Cardiology, NorthShore University HealthSystem, Evanston Hospital, Evanston, Illinois

Disclosures

Disclosure: Rena L. Silver, APN, CNP, has disclosed no relevant financial relationships.

Ms. Silver does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Ms. Silver does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

Ronald K. Miller, PhD

Scientific Director, Medscape, LLC

Disclosures

Disclosure: Ronald K. Miller, PhD, has disclosed no relevant financial relationships.

CME Reviewer(s)

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Peer Reviewer

The Peer Reviewer has disclosed no financial relationships.

Accreditation Statements

For Physicians

Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Cardiology

CME

A Case-Based Approach to Improve Strategies to Reduce Risk for SCA Post-PCI

Authors: Ted E. Feldman, MD; Westby G. Fisher, MD; Rena L. Silver, APN, CNPFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME Released: 9/20/2011; Reviewed and Renewed: 4/15/2014

Valid for credit through: 4/15/2015, 11:59 PM EST

Transcript

processing....

Implantable cardioverter-defibrillators (ICDs) prolong life in patients with depressed ejection fractions (EFs), especially in cases where the patient has had a cardiac arrest or a life-threatening arrhythmia. However, there is a larger group of patients who are potentially at risk for SCA, which includes those who have coronary disease, may have been recently revascularized, or have a reduced EF but have not yet had an event. A team approach with the interventionalist and electrophysiologist along with the nursing team needs to consider all the options during this vulnerable period following percutaneous coronary intervention (PCI). ICDs are not indicated within the first 40 days, yet this is the highest-risk period for sudden cardiac death. Drs. Ted Feldman and Westby Fisher are joined by nurse practitioner Rena Silver for a discussion on options for getting the post-myocardial infarction/post-PCI patient through this difficult period safely.

This feature requires the newest version of Flash. You can download it here.

CME Information Download Slides

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or companies that support educational programming on medscape.org. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Faculty and Disclosures

Moderator(s)

Ted E. Feldman, MD

Presenter(s)

Westby G. Fisher, MD

Rena L. Silver, APN, CNP

Editor(s)

Ronald K. Miller, PhD

CME Reviewer(s)

Nafeez Zawahir, MD

Peer Reviewer

CME

A Case-Based Approach to Improve Strategies to Reduce Risk for SCA Post-PCI

Target Audience and Goal Statement

Disclosures

Moderator(s)

Ted E. Feldman, MD

Presenter(s)

Westby G. Fisher, MD

Rena L. Silver, APN, CNP

Editor(s)

Ronald K. Miller, PhD

CME Reviewer(s)

Nafeez Zawahir, MD

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

A Case-Based Approach to Improve Strategies to Reduce Risk for SCA Post-PCI